BioPharmGuy logo
Sponsored By:
Sponsorship Available
Purchase the BioPharmGuy data
Sinclair Research
Viventia is defunct.

Fate: Acquired by Eleven Bio, Sept 2016, $30M in stock


------------------
If you believe any of this information is incorrect, please let us know.